How to Tell If You Have Chronic Inflammation: Experts Explain Why It Can Be So Dangerous
https://www.popsugar.com/fitness/What-Chronic-Inflammation-45114837

Phase 1 Trial Targets The Immune System, Not The Cancer
https://www.clinicalleader.com/doc/phase-trial-targets-the-immune-system-not-the-cancer-0001

“Senior Staff Snobbery separates Academia from the Biotech Industry”
https://labiotech.eu/interviews/mark-lowdell-interview-academia-biotech/

Clinical Leader (UVPM: 43,896): Phase 1 Trial Targets The Immune System, Not The Cancer
Healthcare Global (UVPM: 5,208): The shift to tumour-agnostic immunotherapies
Phase I Clinical Trial of INB03 coverage:Pharma Journalist (UVPM: 11,130): INmune Bio Initiates Phase I Clinical Trial Of INB03
R&D Mag(UVPM: 219,360): Clinical Trial Investigates Novel Innate Immune System Checkpoint Inhibitor for Solid Tumors

PopSugar(UVPM: 20,660,000): How to Tell If You Have Chronic Inflammation: Experts Explain Why It Can Be So Dangerous PopSugar pickup:Blogarama(UVPM: 243,150)
Bisman Area News(UVPM: 3,780)
EveryBiteFitness(UVPM: 1,230)
Health Gym Fitness Center Blog(UVPM: 1,000)
iStackr(UVPM: 11,220)
MSN.com(UVPM: 656,252,070)
Supreme Health Fitness Blog(UVPM: 1,590)

STAT (UVPM: 2,930,000): Combination immunotherapy may have failed in the Incyte/Merck trial, but it’s here to stay STAT pickup:BioPortfolio(UVPM: 144,690)
Generic Medicine(UVPM: 2,160)
Kaiser Health News(UVPM: 128,310)

The Hill (UVPM: 12,747,900): Cutting costs could be the key to curing cancer 

 

Have a Question?
858 964 3720
Email Us
dmoss@inmunebio.com
Opening Hours
M - F 8am to 5pm PST